Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer - Concepedia

Concepedia

Publication | Closed Access

Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer

59

Citations

39

References

2003

Year

Bridget N. Fahy, Michael G. Schlieman, S. Virudachalam, Richard J. Bold

Journal of Surgical Research

Pancreatic CancerMedicinePharmacologyProteasome Inhibitor BortezomibSchedule-dependent Molecular EffectsAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1